Results 11 to 20 of about 1,194,975 (181)
Drug Development Concerning Metallo-β-Lactamases in Gram-Negative Bacteria [PDF]
β-Lactams have been a clinical focus since their emergence and indeed act as a powerful tool to combat severe bacterial infections, but their effectiveness is threatened by drug resistance in bacteria, primarily by the production of serine- and metallo-β-
Xiuyun Li
exaly +4 more sources
Metallo-β-Lactamases and Aptamer-Based Inhibition
An evolution of antibiotic-resistant bacteria has resulted in the need for new antibiotics. β-Lactam based drugs are the most predominantly prescribed antibiotics to combat bacterial infections; however, production of β-lactamases, which catalyze the ...
Sung-Kun Kim +3 more
doaj +2 more sources
Elucidation of critical chemical moieties of metallo-β-lactamase inhibitors and prioritisation of target metallo-β-lactamases. [PDF]
The urgent demand for effective countermeasures against metallo-β-lactamases (MBLs) necessitates development of novel metallo-β-lactamase inhibitors (MBLIs).
Lee JH +7 more
europepmc +3 more sources
A DNA aptamer reveals an allosteric site for inhibition in metallo-β-lactamases. [PDF]
The hydrolysis of β-lactam antibiotics by β-lactamase enzymes is the most prominent antibiotic resistance mechanism for many pathogenic bacteria. Out of this broad class of enzymes, metallo-β-lactamases are of special clinical interest because of their ...
Nazmul H Khan +6 more
doaj +2 more sources
Dynamically chiral phosphonic acid-type metallo-β-lactamase inhibitors
Abstract Antibiotic resistance is a growing global health threat that risks the lives of millions. Among the resistance mechanisms, that mediated by metallo-β-lactamases is of particular concern as these bacterial enzymes dismantle most β-lactam antibiotics, which are our widest applied and cheapest to produce antibiotic agents.
Kinga Virág Gulyás +19 more
openaire +6 more sources
Antifungal Agent Tavaborole as a Potential Broad-Spectrum Serine and Metallo-β-Lactamases Inhibitor [PDF]
Junfeng Liu, Yang Wang, Huangwei Song
exaly +2 more sources
Strategies to Name Metallo-β-Lactamases and Number Their Amino Acid Residues. [PDF]
Metallo-β-lactamases (MBLs), also known as class B β-lactamases (BBLs), are Zn(II)-containing enzymes able to inactivate a broad range of β-lactams, the most commonly used antibiotics, including life-saving carbapenems. They have been known for about six
Oelschlaeger P, Kaadan H, Dhungana R.
europepmc +2 more sources
New Delhi metallo-β-lactamase variants and different types of metallo-β-lactamases have attracted enormous consideration for hydrolyzing almost all β-lactam antibiotics, which leads to multi drug resistance bacteria.
Azhar Salari-jazi +4 more
doaj +1 more source
Novel metallo β-lactamase mediated by aShigella flexneriplasmid [PDF]
Novel carbapenem-hydrolyzing beta-lactamase (newly named MET-1) encoded on a transferable plasmid pMS390 from Shigella flexneri JS19622 was purified. The molecular weight was 28,000 by SDS-PAGE and the isoelectric point was higher than 9.3. This beta-lactamase favorably hydrolyzed classical cephalosporins and oxyimino-cephalosporins rather than ...
K, O'Hara +4 more
openaire +2 more sources
Controlling the spread of carbapenem-resistant Enterobacterales is a global priority. Using National Healthcare Safety Network data, we characterized the changing epidemiology of carbapenem-resistant Klebsiella pneumoniae (CRKP) in a large public health
Jennifer Lee +7 more
doaj +1 more source

